ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 103 filers reported holding ANTARES PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,166,000 | -7.1% | 530,246 | -16.0% | 0.00% | 0.0% |
| Q4 2017 | $1,255,000 | -5.4% | 631,049 | +54.3% | 0.00% | 0.0% |
| Q3 2017 | $1,326,000 | +2.1% | 408,944 | +1.2% | 0.00% | 0.0% |
| Q2 2017 | $1,299,000 | +6736.8% | 403,975 | +2483.8% | 0.00% | – |
| Q4 2015 | $19,000 | +5.6% | 15,635 | +46.1% | 0.00% | – |
| Q3 2015 | $18,000 | -45.5% | 10,704 | -32.9% | 0.00% | – |
| Q2 2015 | $33,000 | -2.9% | 15,951 | +25.7% | 0.00% | – |
| Q1 2015 | $34,000 | +9.7% | 12,685 | +6.6% | 0.00% | – |
| Q4 2014 | $31,000 | +10.7% | 11,902 | +13.4% | 0.00% | – |
| Q2 2014 | $28,000 | -45.1% | 10,492 | -8.6% | 0.00% | – |
| Q4 2013 | $51,000 | +15.9% | 11,481 | +6.4% | 0.00% | – |
| Q3 2013 | $44,000 | +4.8% | 10,793 | +7.1% | 0.00% | – |
| Q2 2013 | $42,000 | – | 10,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WILLIAM HARRIS INVESTORS INC | 2,338,735 | $6,244,000 | 1.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,603,703 | $25,642,000 | 1.03% |
| Broadfin Capital, LLC | 6,100,000 | $16,288,000 | 0.80% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,088,675 | $2,907,000 | 0.58% |
| MARINER INVESTMENT GROUP LLC | 296,477 | $792,000 | 0.15% |
| THOMPSON DAVIS & CO., INC. | 36,500 | $97,000 | 0.14% |
| Peregrine Asset Advisers, Inc. | 53,034 | $142,000 | 0.13% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,165,738 | $3,101,000 | 0.12% |
| Avenir Corp | 341,035 | $911,000 | 0.08% |
| Brown Advisory Securities, LLC | 50,550 | $135,000 | 0.05% |